Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma
Multiple myeloma (MM) progression is dependent on its interaction with the bone marrow microenvironment and the immune system and is mediated by key surface antigens. Some antigens promote adhesion to the bone marrow matrix and stromal cells, while others are involved in intercellular interactions t...
Main Authors: | Eyal Lebel, Boaz Nachmias, Marjorie Pick, Noa Gross Even-Zohar, Moshe E. Gatt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/7/1809 |
Similar Items
-
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
by: Noa Gross Even-Zohar, et al.
Published: (2022-05-01) -
Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy
by: Maiko Matsushita, et al.
Published: (2020-10-01) -
Minimal residual disease in plasma cell (multiple) myeloma: flow cytometric approaches
by: L. Yu. Grivtsova, et al.
Published: (2020-04-01) -
Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients
by: Mihaiela L. Dragoș, et al.
Published: (2022-07-01) -
Role of flow cytometry in multiple myeloma and the prognostic significance of CD87 (uPAR) expression
by: Murat Albayrak, et al.
Published: (2010-10-01)